This federal contract award, with ID SPE2DX21D3133|SPE2DX21FMV03, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,460.74 delivery order contract is for the provision of pharmaceutical products, medical supplies, and healthcare solutions to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of essential pharmaceutical and medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, across multiple therapeutic areas. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.
Generated 2/27/25, 9:47 AM